# PVI Alone Versus PVI Plus PWI and SVCI With PFA

Study · id `cardio:ct-nct07405359` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07405359](<https://clinicaltrials.gov/study/NCT07405359>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07405359

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.

## Technical summary

Registry record NCT07405359. Randomized; single masking; primary purpose treatment. Start 2026-04-03 (actual); primary completion 2028-08-14 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 220 participants (planned count; ClinicalTrials.gov record NCT07405359, source copy `cardio:ctgov-nct07405359-2026-07-14`, retrieved 2026-10-26)
- Started: 2026-04-03 (actual) (ClinicalTrials.gov record NCT07405359, source copy `cardio:ctgov-nct07405359-2026-07-14`, retrieved 2026-10-26)
- Primary completion: 2028-08-14 (anticipated) (ClinicalTrials.gov record NCT07405359, source copy `cardio:ctgov-nct07405359-2026-07-14`, retrieved 2026-10-26)
- Completion: 2028-08-14 (anticipated) (ClinicalTrials.gov record NCT07405359, source copy `cardio:ctgov-nct07405359-2026-07-14`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07405359, source copy `cardio:ctgov-nct07405359-2026-07-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07405359-2026-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: PVI Alone Versus PVI Plus PWI and SVCI With PFA
- Acronym: PVI-PLUS
- Condition: Persistent Atrial Fibrillation
- Intervention (Procedure): AF Ablation: PVI + PWI + SVCI
- Intervention (Device): PFA
- Intervention (Procedure): Implantable loop recorder
- Lead sponsor: Edward Gerstenfeld, MD
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: f571b57e4863c3b0a890bf90e31fba3c96a8a4f7649c79dca0778715ccbb9449
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
